Many pharma companies chase advanced AI without solving the foundational challenge of data integration. With only 10% of firms having unified data, true personalization is impossible until a central data platform is established to break down the typical 100+ data silos.
Companies struggle with AI not because of the models, but because their data is siloed. Adopting an 'integration-first' mindset is crucial for creating the unified data foundation AI requires.
The primary barrier to deploying AI agents at scale isn't the models but poor data infrastructure. The vast majority of organizations have immature data systems—uncatalogued, siloed, or outdated—making them unprepared for advanced AI and setting them up for failure.
Companies run numerous disconnected AI pilots in R&D, commercial, and other silos, each with its own metrics. This fragmented approach prevents enterprise-wide impact and disconnects AI investment from C-suite goals like share price or revenue growth. The core problem is strategic, not technical.
Before implementing AI, organizations must first build a unified data platform. Many companies have multiple, inconsistent "data lakes" and lack basic definitions for concepts like "customer" or "transaction." Without this foundational data consolidation, any attempt to derive insights with AI is doomed to fail due to semantic mismatches.
AI models fail in business applications because they lack the specific context of an organization's operations. Siloed data from sales, marketing, and service leads to disconnected and irrelevant AI-driven actions, making agents seem ineffective despite their power. Unified data provides the necessary 'corporate intelligence'.
Many pharma companies have breakthrough AI results in isolated functions, or "pockets of excellence." However, the ultimate competitive advantage will go to the company that first connects these disparate successes into a single, integrated, enterprise-wide AI capability, thereby creating compounded value across the organization.
Companies struggle to get value from AI because their data is fragmented across different systems (ERP, CRM, finance) with poor integrity. The primary challenge isn't the AI models themselves, but integrating these disparate data sets into a unified platform that agents can act upon.
Pharma companies engaging in 'pilotitis'—running random, unscalable AI projects—are destined to fall behind. Sustainable competitive advantage comes from integrating AI across the entire value chain and connecting it to core business outcomes, not from isolated experiments.
According to Salesforce's AI chief, the primary challenge for large companies deploying AI is harmonizing data across siloed departments, like sales and marketing. AI cannot operate effectively without connected, unified data, making data integration the crucial first step before any advanced AI implementation.
Many companies focus on AI models first, only to hit a wall. An "integration-first" approach is a strategic imperative. Connecting disparate systems *before* building agents ensures they have the necessary data to be effective, avoiding the "garbage in, garbage out" trap at a foundational level.